One major goal of an effective liver-stage malaria vaccine is to generate a repository of long-lasting, antigen-specific, memory CD8+ T cells in the liver, which will be readily available to fight potential malaria liver-stage infections (8). The gene discussed is CD8A; the disease is infection.